The Synthesis and Biological Evaluation of N-Substituted 1H-Benzimidazol-2-yl-1H-pyrazole-3,5-diamines

0460144 - ÚEB 2017 RIV US eng J - Článek v odborném periodiku
Jedinák, L. - Kryštof, Vladimír - Cankař, P.
The Synthesis and Biological Evaluation of N-Substituted 1H-Benzimidazol-2-yl-1H-pyrazole-3,5-diamines.
Journal of Heterocyclic Chemistry. Roč. 53, č. 2 (2016), s. 499-507. ISSN 0022-152X. E-ISSN 1943-5193
Institucionální podpora: RVO:61389030
Klíčová slova: ONE-POT SYNTHESIS * BENZIMIDAZOLE DERIVATIVES * EFFICIENT SYNTHESIS
Kód oboru RIV: CE - Biochemie
Impakt faktor: 0.893, rok: 2016

The synthesis of 1H-benzimidazol-2-yl-1H-pyrazole-3,5-diamines has been developed. Synthesized bisheteroaryls contain two privileged medicinal scaffolds, aminopyrazole and benzimidazole, with two diversity positions at N1 of benzimidazole and C3 of pyrazole, respectively. The three-step synthesis includes the Mitsunobu N-alkylation of benzimidazole and subsequent one-pot formation of aminopyrazole involving substitution of methylthio groups with amine and hydrazine followed with final ring closure. Inhibitory activity toward cyclin-dependent kinase 2/cyclin E and cytotoxicity against two cancer cell lines were evaluated for all novel pyrazoles. Two compounds showed modest cyclin-dependent kinase inhibition activity and cytotoxicity against cancer cell lines K562 and MCF7.
Trvalý link: http://hdl.handle.net/11104/0260264